1. Home
  2. KELYB vs ORIC Comparison

KELYB vs ORIC Comparison

Compare KELYB & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$23.47

Market Cap

814.8M

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$13.93

Market Cap

861.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
ORIC
Founded
1946
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.8M
861.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KELYB
ORIC
Price
$23.47
$13.93
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$19.73
AVG Volume (30 Days)
853.0
1.7M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
19.67
EPS
0.15
N/A
Revenue
$5,355,600,000.00
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$156.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$7.23
52 Week High
$125.00
$14.93

Technical Indicators

Market Signals
Indicator
KELYB
ORIC
Relative Strength Index (RSI) 55.37 63.52
Support Level $11.66 $10.45
Resistance Level $24.78 $14.14
Average True Range (ATR) 0.55 0.88
MACD -0.18 0.05
Stochastic Oscillator 72.88 83.69

Price Performance

Historical Comparison
KELYB
ORIC

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: